Parkinson’s Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy

Home » Parkinson’s Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy

By Medco PRF|2022-01-15T04:56:32-06:00October 26th, 2021|Articles|0 Comments

About PRF

PRF (Platelet Rich Fibrin) was first developed and invented in France by Dr. Joseph Choukroun in the field of Oral and Maxillofacial Surgery.